NEWS
Firstword Healthtech | FDA clears Biotricity’s Biotres cardiac monitoring device

Biotricity said Monday that it received FDA 510(k) clearance for its Biotres cardiac monitoring device, a three-lead holter for continuous electrocardiogram and arrhythmia monitoring in lower risk patients. Biotres will be widely available for sale from April 1. CEO Waqaas Al-Siddiq remarked that the device “is designed for comfort for long-term wear.” He added that “cardiac […]

Healio | Three-lead Holter monitor for low-risk patients gains FDA 510(k) clearance

Biotricity announced it received 510(k) clearance from the FDA for its three-lead device for ECG and arrhythmia monitoring for use among lower risk patients. “Biotres is a Holter for low-risk patients and is designed for comfort for long-term wear,” Waqaas Al-Siddiq, founder and CEO of Biotricity, said in a press release from the company. “Cardiac disease […]

HIT Consultant | Biotricity Awarded FDA 510(k) Clearance for Cardiac Monitoring Device

What You Should Know: – Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three-lead device for ECG and arrhythmia monitoring that is intended for lower-risk patients. – Most remote cardiac monitors are passive […]